Lipid-based Polyene Antifungal [EPC]

12863 reported adverse events

Drugs of this class: AMPHOTERICIN B AMPHOTERICIN B LIPOSOME

These side effects are most commonly reported by patients taking drugs of the Lipid-based Polyene Antifungal [EPC] class:

# Side effect Count
0 DRUG INEFFECTIVE 4204
1 OFF LABEL USE 1800
2 CONDITION AGGRAVATED 839
3 PYREXIA 824
4 PRODUCT USE IN UNAPPROVED INDICATION 556
5 ACUTE KIDNEY INJURY 553
6 MULTIPLE ORGAN DYSFUNCTION SYNDROME 549
7 SEPSIS 488
8 FEBRILE NEUTROPENIA 483
9 NEUTROPENIA 456
See all common reactions for Lipid-based Polyene Antifungal [EPC]

Drugs of the Lipid-based Polyene Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHOROIDITIS 73 0.1952
1 DISSEMINATED MUCORMYCOSIS 65 0.1650
2 FUNGAL ENDOCARDITIS 48 0.1595
3 FUSARIUM INFECTION 111 0.1586
4 CEREBRAL ASPERGILLOSIS 87 0.1415
5 RHINOCEREBRAL MUCORMYCOSIS 49 0.1412
6 TRICHOSPORON INFECTION 56 0.1383
7 SCEDOSPORIUM INFECTION 85 0.1204
8 MUCORMYCOSIS 306 0.1176
9 PULMONARY MUCORMYCOSIS 61 0.1155
See all enriched reactions for Lipid-based Polyene Antifungal [EPC]